Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration

Journal of Investigative Dermatology

Volumn 122, Issue 5, 2004, Pages 1154-1164

  Aeby, Pierre ^a,d   Wyss, Christoph ^a   Beck, Heinz ^a   Griem, Peter ^c   Scheffler, Heike ^b   Goebel, Garsten ^b  

^a Wella Cosmital SA   (Switzerland)

^b Wella AG   (Germany)

^c CLARIANT PRODUKTE DEUTSCHLAND GMBH   (Germany)

^d NONE   (Switzerland)

Author keywords

Aquaporins; CD86 antigen; Hair dyes; IL 1 ; LLNA

Indexed keywords

4 TOLUYLENEDIAMINE; ACETONE; AQUAPORIN 3; AROMATIC AMINE; CD86 ANTIGEN; CHEMICAL AGENT; DIMETHYL SULFOXIDE; DODECYL SULFATE SODIUM; DRUG VEHICLE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYETHYL 4 PHENYLENEDIAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; IRRITANT AGENT; OLIVE OIL; PENETRATION ENHANCING AGENT; PRIMER RNA; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGENIC MODULATION; ARTICLE; BIOAVAILABILITY; CELL ACTIVATION; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; LOCAL LYMPH NODE ASSAY; MALE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN PENETRATION; SKIN SENSITIZATION; SWINE;

EID: 2442482408     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22402.x     Document Type: Article

References (54)

1. Aeby P, Bracher M: Evaluation of CD86 modulation and IL-1β gene expression on cultured dendritic-like cells as predictive endpoints for contact sensitizers. ATLA 27:359, 1999 (abstract)
2. Aiba S, Manome H, Yoshino Y, Tagami H: In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101:63-75, 2000
3. Aiba S, Tagami H: Dendritic cells play a crucial role in innate immunity to simple chemicals. J Invest Dermatol Symp Proc 4:158-163, 1999
4. Aiba S, Terunuma A, Manome H, Tagami H: Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 27:3031-3038, 1997
5. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C: A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166:3837-45, 2001
6. Basketter DA, Blaikie L, Dearman RJ, et al: Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 42:344-348, 2000
7. Basketter DA, Gerberick GF, Kimber I: Skin sensitisation, vehicle effects and the local lymph node assay. Fd Chem Toxicol 39:621-627, 2001
8. Beck H, Bracher M, Faller C, Hofer H: Comparison of in vitro and in vivo skin permeation of hair dyes. Cosmet Toiletries 108:76-83, 1993
9. Becker D, Valk E, Zahn S, Brand P, Knop J: Coupling of contact sensitizers to thiol groups is a key event for the activation of monocytes and monocyte-derived dendritic cells. J Invest Dermatol 120:233-238, 2003
10. Bracher M, Faller C, Noser FK: Evaluation of an in vitro percutaneous permeation model with two oxidative hair dyes. Int J Cosmet Sci 9:223-236, 1987
11. de Baey A, Lanzavecchia A: The role of aquaporins in dendritic cell macropinocytosis. J Exp Med 191:743-747, 2000
12. de Saint-Vis B, Fugier-Vivier I, Massacrier C, et al: The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 160:1666-1676, 1998
13. De Smedt AC, Van Den Heuvel RL, Van Tendeloo VF, Berneman ZN, Schoeters GE, Weber E, Tuschl H: Phenotypic alterations and IL-1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: A comparative analysis. Arch Dermatol 294:109-116, 2002
14. Degwert J, Steckel F, Hoppe U, Kligman LH: In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicol In Vitro 11:613-618, 1997
15. Depraetere S, Vanhaesebroeck B, Fiers W, Willems J, Joniau M: Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines. J Leucoc Biol 57:141-151, 1995
16. Ebner S, Neyer S, Hofer S, Nussbaumer W, Romani N, Heufler C: Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: An alternative to standard buffy coats. J Immunol Meth 252:93-104, 2001
17. Enk AH, Angeloni VL, Udey MC, Katz SI: An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 150:3698, 1993
18. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci 89:398-1402, 1992
19. Guironnet G, Dalbiez-Gauthier C, Rousset F, Schmitt D, Peguet-Navarro J: In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. Toxicol In vitro 14:517-522, 2000
20. Hulette BA, Ryan CA, Gerberick GF: Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol Appl Pharmacol 182:226-233, 2002
21. Katayama I, Matsunaga K, Yokozeki H, Nishikoa K: Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells. Br J Dermatol 136:846-852, 1997
22. Kermani F, Flint MS, Hotchkiss SAM: Induction and localization of cutaneous interleukin-1 mRNA during contact sensitization. Toxicol Appl Pharmacol 169:231-237, 2000
23. Kim N, El-Khalili M, Henary MM, Strekowski L, Michniak BB: Percutaneous penetration enhancement activity of aromatic S, S-dimethyliminosulfuranes. Int J Pharm 187:219-229, 1999
24. Kimber I, Basketter DA: The murine local lymph node assay: A commentary on collaborative studies and new directions. Fd Chem Toxicol 30:165-169, 1992
25. Kimber I, Dearman RJ, Cumberbatch M, Huby RJD: Langerhans cells and chemical allergy. Curr Opin Immunol 10:614-619, 1998
26. Kimber I, Pichowski JS, Betts CJ, Cumberbatch M, Basketter DA, Dearman RJ: Alternative approaches to the identification and characterization of chemical allergens. Toxicol In Vitro 15:307-312, 2001
27. Lea LJ, Warbrick EV, Dearman RJ, Kimber I, Basketter DA: The impact of vehicle on assessment of relative skin sensitization potency of 1,4-dihydroquinone in the local lymph node assay. Am J Cont Derm 10:213-218, 1999
28. Lenz A, Heine M, Schuler G, Romani N: Human and murine dermis contain dendritic cells. J Clin Invest 92:2587-2596, 1993
29. Lepoittevin JP, Basketter DA, Goossens A, Karlberg A-T In: Karlberg A-T (ed) Allergic Contact Dermatitis - The Molecular Basis. Berlin: Springer-Verlag, 1998
30. Loré K, Sönnerborg A, Spetz AL, Andersson U, Andersson J: Erratum to "Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells." J Immunol Meth 218:173-187, 1998
31. Malkowski J, Klenieswka D, Maibach H: Relationship between chemical structure and allergenicity: Aromatic amines. Occup Environ Dermatol 31:48-50, 1983
32. Mellman I, Steinman RM: Dendritic cells specialized and regulated antigen processing machines. Cell 106:255-258, 2001
33. Noser FK, Faller C, Bracher M: In vitro permeation with pig skin: Instrumentation and comparison of flow-through versus static-diffusion protocol. J Appl Cosmetol 6:111-122, 1988
34. Ozawa H, Nakagawa S, Tagami H, Aiba S: Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441, 1996
35. Pichowski JS, Cumberbatch M, Dearman RJ, Basketter DA, Kimber I: Investigation of induced changes in interleukin 1β mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicol In Vitro 14:351-360, 2000
36. Pichowski JS, Cumberbatch M, Dearman RJ, Basketter DA, Kimber I: Allergen-induced changes in interleukin 1 beta mRNA expression by human blood-derived dendritic cells: Inter-individual differences and relevance for sensitization testing. J Appl Toxicol 21:115-121, 2001
37. Priborsky J, Muhlbachova E: Evaluation of in-vitro percutaneous absorption across human skin and in animal models. J Pharm Pharmacol 42:468-472, 1990
38. Rambukkana A, Pistoor FHM, Bos JD, Kapsenberg ML, Das PK: Effects of contact allergens on human Langerhans cells in skin organ culture: Migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein. Lab Invest 74:422-436, 1996
39. Reutter K, Jaeger D, Degwert J, Hoppell: In vitro model for contact sensitization: II. Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitizers. Toxicol In Vitro 11:619-626, 1997
40. Robinson KM: Optimization of an in vitro lymphocyte blastogenesis assay for predictive assessment of immunologic responsiveness to contact sensitizers. J Invest Dermatol 92:860-867, 1989
41. Romani N, Gruner S, Brang D, et al: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93, 1994
42. Rougier N, Redziniak G, Mougin D, Schmitt D, Vincent C: In vitro evaluation of the sensitization potential of weak contact allergens using langerhans-like dendritic cells and autologous T cells. Toxicology 145:73-82, 2000
43. Ryan CA, Cruse LW, Skinner RA, Dearman RJ, Kimber I, Gerberick GF: Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Fd Chem Toxicol 40:1719-1725, 2002
44. Ryan CA, Hulette BC, Gerberick GF: Approaches for the development of cell-based in vitro methods for contact sensitization. Toxicol In Vitro 15:43-55, 2001
45. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118, 1994
46. Schmook FP, Meingassner JG, Billich A: Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 215:51-56, 2001
47. Simon GA, Maibach HI: The pig as an experimental animal model of percutaneous permeation in man: Qualitative and quantitative observations - an overview. Skin Pharmacol Appl Skin Physiol 13:229-234, 2000
48. Sjogren F, Anderson C: The spectrum of inflammatory cell response to dimethyl sulfoxide. Contact Dermatitis 42:216-221, 2000
49. Smith CK, Hotchkiss SAM: Allergic Contact Dermatitis - Chemical and Metabolic Mechanisms. London and New York: Taylor & Francis, 2001
50. Stoitzner P, Holzmann S, McLellan AD, et al: Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 120:266-274, 2003
51. Tuschl H, Kovac R: Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicol In Vitro 15:327-331, 2001
52. Uter W, Geier J, Schnuch A: Current pattern and trends in sensitization to hairdressers allergens in Germany. Occup Environ Dermatol 48:55-59, 2000
53. Warbrick EV, Dearman RJ, Basketter DA, Kimber I: Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/ methylisothiazolinone: An analysis using the local lymph node assay. Contact Dermatitis 41:325-329, 1999
54. Wright ZM, Basketter DA, Blaikie L, Cooper KJ, Warbrick EV, Dearman RJ, Kimber I: Vehicle effects on skin sensitizing potency of four chemicals: Assessment using the local lymph node assay. Int J Cosmet Sci 23:75-83, 2001